GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
2.775
+0.025 (0.91%)
Jul 22, 2024, 10:17 AM EDT - Market open
GT Biopharma Employees
GT Biopharma had 2 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$4,818,000
Market Cap
5.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
Ainos | 46 |
ReShape Lifesciences | 29 |
Hepion Pharmaceuticals | 22 |
TFF Pharmaceuticals | 19 |
Soligenix | 15 |
Sonoma Pharmaceuticals | 10 |
Pasithea Therapeutics | 8 |
GTBP News
- 25 days ago - GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia - GlobeNewsWire
- 2 months ago - GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - What made GT Biopharma stock more than double on Monday? - Invezz
- 2 months ago - GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results - GlobeNewsWire
- 6 months ago - GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split - GlobeNewsWire
- 8 months ago - Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders - GlobeNewsWire
- 8 months ago - GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia - GlobeNewsWire